Headwinds in remission; revenues of ICRA’s sample set of Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA Read more
US FDA issues Form-483 with eight observations to Lupin’s drug, API production facilities in Mandideep plant Read more